CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial | BioSpace

CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today annou

1. CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial | BioSpace